Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Current Drug Metabolism|April 19, 2011
Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practiceAlberto Pilotto, Francesco Panza, Davide Seripa
Parkinson'S Disease|March 5, 2016
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's DiseaseLetizia Polito, Antonio Greco, Davide Seripa
Molecular Neurobiology|December 10, 2016
Looking Beyond the 5-HTTLPR Polymorphism: Genetic and Epigenetic Layers of Regulation Affecting the Serotonin Transporter Gene ExpressionSandra Iurescia, Davide Seripa, Monica Rinaldi
Journal of Alzheimer'S Disease : JAD|March 19, 2019
Understanding the Amyloid Hypothesis in Alzheimer's DiseaseGiulia Paroni, Paola Bisceglia, Davide Seripa
Molecular Neurobiology|October 15, 2015
Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic VariantsSandra Iurescia, Davide Seripa, Monica Rinaldi
Annals of Neurology|January 13, 2019
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?Francesco Panza, Madia Lozupone, Davide Seripa, et al.
Journal of the American Geriatrics Society|December 15, 2010
Plasma lipid disturbances and cognitive declineVincenza Frisardi, Francesco Panza, Vincenzo Solfrizzi, et al.
Journal of the American Geriatrics Society|November 9, 2010
Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotypingFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Frontiers of Neurology and Neuroscience|July 28, 2016
Pharmacogenetics in Neurodegenerative Diseases: Implications for Clinical TrialsRosanna Tortelli, Davide Seripa, Francesco Panza, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2015
Measuring pharmacogenetics in special groups: geriatricsDavide Seripa, Francesco Panza, Julia Daragjati, et al.
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Current Drug Metabolism|April 19, 2011
Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practiceAlberto Pilotto, Francesco Panza, Davide Seripa
Parkinson'S Disease|March 5, 2016
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's DiseaseLetizia Polito, Antonio Greco, Davide Seripa
Molecular Neurobiology|December 10, 2016
Looking Beyond the 5-HTTLPR Polymorphism: Genetic and Epigenetic Layers of Regulation Affecting the Serotonin Transporter Gene ExpressionSandra Iurescia, Davide Seripa, Monica Rinaldi
Journal of Alzheimer'S Disease : JAD|March 19, 2019
Understanding the Amyloid Hypothesis in Alzheimer's DiseaseGiulia Paroni, Paola Bisceglia, Davide Seripa
Molecular Neurobiology|October 15, 2015
Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic VariantsSandra Iurescia, Davide Seripa, Monica Rinaldi
Annals of Neurology|January 13, 2019
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?Francesco Panza, Madia Lozupone, Davide Seripa, et al.
Journal of the American Geriatrics Society|December 15, 2010
Plasma lipid disturbances and cognitive declineVincenza Frisardi, Francesco Panza, Vincenzo Solfrizzi, et al.
Journal of the American Geriatrics Society|November 9, 2010
Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotypingFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Frontiers of Neurology and Neuroscience|July 28, 2016
Pharmacogenetics in Neurodegenerative Diseases: Implications for Clinical TrialsRosanna Tortelli, Davide Seripa, Francesco Panza, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2015
Measuring pharmacogenetics in special groups: geriatricsDavide Seripa, Francesco Panza, Julia Daragjati, et al.
Pageof 23